Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Tazarotene gel may be more effective for acne than adapalene gel.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Baricitinib was effective in treating alopecia areata in two major trials.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A new teledermatology system improved access and reduced wait times for skin care.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.